| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 201,836 | 179,893 | 161,334 | | Cost of Revenue | 98,540 | 98,929 | 85,523 | | | Gross Profit | 103,296 | 80,964 | 75,811 | | | Operating Expenses | | Research Development | 43,042 | 42,699 | 40,917 | | Selling General and Administrative | 48,485 | 43,356 | 41,576 | | Non Recurring |
-
|
-
|
-
| | Others | 1,575 | 2,952 | 5,664 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 10,194 | (8,043) | (12,346) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,182 | 12,012 | 1,301 | | Earnings Before Interest And Taxes | 11,376 | 3,969 | (11,045) | | Interest Expense | 57 | 54 | 96 | | Income Before Tax | 11,319 | 3,915 | (11,141) | | Income Tax Expense | 575 | 2,156 | (1,632) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,974 | 2,902 | (8,237) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 9,974 | 2,902 | (8,237) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,974 | $2,902 | ($8,237) |
|
1.48% Nasdaq 
Income Statement
